| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/29/2004 | WO2004009086A1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 01/29/2004 | WO2004009085A2 Taste masked sumatriptan tablets and processes for their preparation |
| 01/29/2004 | WO2004009084A1 Methods of treating infection using antibiotics and glycogen phosphorylase inhibitors |
| 01/29/2004 | WO2004009083A1 Antitumor compound and therapeutic uses thereof |
| 01/29/2004 | WO2004009082A1 Oxime conjugates and methods for their formation and use |
| 01/29/2004 | WO2004009081A1 Use of neomycin in the preparation of medicaments that are used in the treatment of diseases caused by hyperactivation of kinase proteins activated by mitogens (mapk) or by transcription factors |
| 01/29/2004 | WO2004009080A1 Levamisole, Avermectins or similar in pyrrolidone solvent |
| 01/29/2004 | WO2004009078A1 Cancer chemopreventative compounds and compositions and methods of treating cancers |
| 01/29/2004 | WO2004009077A1 TASTE-MASKED LIQUID PHARMACEUTICAL COMPOSITION COMPRISING A COMPLEX OF A HISTAMINE h2-RECEPTOR ANTAGONIST AND ALGINATE |
| 01/29/2004 | WO2004009076A1 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof |
| 01/29/2004 | WO2004009075A1 Composition for solubilization of paclitaxel and preparation method thereof |
| 01/29/2004 | WO2004009074A2 A multi-ring regulator of gut motility and food intake |
| 01/29/2004 | WO2004009073A1 P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient |
| 01/29/2004 | WO2004009072A2 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 01/29/2004 | WO2004009071A1 Conjugated linoleic acid powder |
| 01/29/2004 | WO2004009070A1 Calcium lactate and whey permeate for lowering the triglyceride level |
| 01/29/2004 | WO2004009069A1 Treatment of depression secondary to pain (dsp) |
| 01/29/2004 | WO2004009068A2 Compounds with antiparasitic activity and medicines containing same |
| 01/29/2004 | WO2004009067A1 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence |
| 01/29/2004 | WO2004009066A1 Novel nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/29/2004 | WO2004009065A1 Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan |
| 01/29/2004 | WO2004009064A1 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 01/29/2004 | WO2004009063A1 TOPICAL ANTIINFLAMMATORY PREPARATIONS OF η-TERPINENE |
| 01/29/2004 | WO2004009062A2 NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau |
| 01/29/2004 | WO2004009061A2 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 01/29/2004 | WO2004009058A1 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| 01/29/2004 | WO2004009056A1 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent |
| 01/29/2004 | WO2004009053A2 Oral delivery system containing a gel matrix and liposomes |
| 01/29/2004 | WO2004009035A2 Compositions and products containing enantiomeric equol, and methods for their making |
| 01/29/2004 | WO2004009030A2 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/29/2004 | WO2004009029A2 Compositions and methods for treating and preventing infection |
| 01/29/2004 | WO2004009026A2 Cholinergic therapy for individuals with learning disabilities |
| 01/29/2004 | WO2004009023A2 Novel inhibitors of ubiquitin isopeptidases |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2004009015A2 Combination therapy for the treatment of obesity |
| 01/29/2004 | WO2004008946A2 Methods of diagnosing and treating pre-eclampsia or clamp |
| 01/29/2004 | WO2003101996A3 Esters in position 20 of camptothecins |
| 01/29/2004 | WO2003101492A3 Combination of atypical antipsychotic and serotonin reuptake inhibitor for the treatment of chronic pain |
| 01/29/2004 | WO2003101462A3 Use of bisphosphonic acid derivatives for the treatment of calcium phrophosphated deposition disease and dental treatment |
| 01/29/2004 | WO2003097021A3 Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea |
| 01/29/2004 | WO2003088748A8 Use of heme oxygenase-1 and products of heme degradation |
| 01/29/2004 | WO2003086362A3 Method of stabilizing bupropion hydrochloride tablets |
| 01/29/2004 | WO2003072572A8 Beta3-adrenergic receptor agonists |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | WO2003061566A3 Anti-cancer combination and use thereof |
| 01/29/2004 | WO2003059864A3 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 01/29/2004 | WO2003059373A3 Compositions and their use for enhancing and inhibiting fertilization |
| 01/29/2004 | WO2003057154A3 Naaladase inhibitors for treating huntington's disease |
| 01/29/2004 | WO2003057153A3 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 01/29/2004 | WO2003053971A8 Pyridoquinoxaline antivirals |
| 01/29/2004 | WO2003053923A3 Pyrrolidine derivatives as prostaglandin modulators |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | WO2003050241A3 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 01/29/2004 | WO2003049705A3 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/29/2004 | WO2003048775A3 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 01/29/2004 | WO2003048184A3 Flavivirus ns1 subunit vaccine |
| 01/29/2004 | WO2003042172A3 C-5 modified indazolylpyrrolotriazines |
| 01/29/2004 | WO2003041638A3 Suppository base |
| 01/29/2004 | WO2003040080A3 Lipoxin a4 analogs |
| 01/29/2004 | WO2003038113A3 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 01/29/2004 | WO2003032924A3 Novel tibolone formulations |
| 01/29/2004 | WO2003032905A3 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 01/29/2004 | WO2003018014A3 Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives |
| 01/29/2004 | WO2003002137A3 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/29/2004 | WO2003000199A3 Ilt3 and ilt4-related compositions and methods |
| 01/29/2004 | WO2003000180A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002066473A8 8’4-’3-(5-fluoro-1h-indol-3yl) propyl!-1-piperazynyl!-2-methyl-2h-1,4-benzoxazin -3 (4h)- one methanesulfonate with high affinity for the dopamine d 2 receptor and the serotonin reuptake site |
| 01/29/2004 | WO2002064014A9 Endomural therapy |
| 01/29/2004 | WO2002038106A3 Calcilytic compounds |
| 01/29/2004 | US20040019919 Calsyntenin-1-3 proteins, predominantly expressed in the nervous system , useful for the screening and for the preparation of a medicament for the treatment of nervous system disorders, most preferably brain |
| 01/29/2004 | US20040019232 Analogs of phosphonate and bisphosphonate compounds based on bone resorption suppressors (alendronic acid), viricides (cidofovir) and antineoplastic agents (bemcitabine); nontoxic; bioavailability; side effects reduction |
| 01/29/2004 | US20040019214 Carbocyclic carbo, oxo amines such as N-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders |
| 01/29/2004 | US20040019211 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 01/29/2004 | US20040019210 Kinase inhibitors |
| 01/29/2004 | US20040019208 5-Aryltetrazole Compounds, compositions thereof, and uses therefor |
| 01/29/2004 | US20040019207 Amines such as 8-Benzyl-3-(3-pyridyl)-8-azabicyclo(3.2.1) oct-2-ene, that bind to nicotinic acetocholine receptors, used for prophylaxis of nervous system disorders, as analgesis, antiinflammatory agents and drug abuse |
| 01/29/2004 | US20040019206 Nitrogen compounds used as cellular adhesion molecule antagonists, for prophylaxis of osteoporosis, restenosis, atheroscelososis, vision defects, retinopathy, arthritis or tumors |
| 01/29/2004 | US20040019203 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| 01/29/2004 | US20040019191 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019184 Remedies for ischemic disease |
| 01/29/2004 | US20040019181 Antimicrobial cationic peptides |
| 01/29/2004 | US20040019130 Aqueous solution mixture of polymer, calcium compound and phosphate; buffered pH |
| 01/29/2004 | US20040019122 Solid dispersion composition |
| 01/29/2004 | US20040019121 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease |
| 01/29/2004 | US20040019120 Laser treatment of cutaneous vascular lesions |
| 01/29/2004 | US20040019118 Therapeutic treatment with a 1-aminocyclohexane derivatives or 1-aminoadamantane compounds, such as mamantine or neramexane; new use of existing drug |
| 01/29/2004 | US20040019117 Anti tubercular drug: compostions and methods |
| 01/29/2004 | US20040019116 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
| 01/29/2004 | US20040019115 Use of milnacipran for the treatment of tension-type headache |
| 01/29/2004 | US20040019114 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 01/29/2004 | US20040019113 Phosphate transport inhibitors |
| 01/29/2004 | US20040019112 Treatment modality and method for fungal nail infection |
| 01/29/2004 | US20040019111 A new use of existing pharmaceutical, a nonsteroidal antiinflammatory agents |
| 01/29/2004 | US20040019110 Lipoxin analogs and method for the treatment of periodontal disease |
| 01/29/2004 | US20040019109 Methods of identifying compounds that affect a fatty acid cell-surface receptor |
| 01/29/2004 | US20040019108 Therapeutic treatment of psoriasis, with a fatty esters, or tetradecylthioacetic acid, or tetradecylselenoacetic acid |
| 01/29/2004 | US20040019107 A carbobenzoxy alanyl taurine has potency for treating virus infection, fatigue, allergic reaction, physiological disorders, metabolic disorders, proliferative disorders, immune dysfunctions, drug abuse; use as bactericides |
| 01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |